Brittany A. Riggle

Brittany A. Riggle

Auto-generated profile, based on publicly available information

Brittany A. Riggle

Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BRBrittany A. Riggle
Brittany A. Riggle
MMMonica Manglani
Monica Manglani
DMDragan Maric
Dragan Maric
KJKory R Johnson
Kory R Johnson
MLMyoung-Hwa Lee
Myoung-Hwa Lee
SPSusan K. Pierce
Susan K. Pierce
BACKGROUND. Cerebral malaria (CM) accounts for nearly 400,000 deaths annually in African children. Current dogma suggests that CM results from infected RBC (iRBC) sequestration in the brain microvasculature and resulting sequelae. Therapies targeting these events have been unsuccessful; findings in experimental models suggest that CD8+ T cells drive disease pathogenesis. However, these data have largely been ignored because corroborating evidence in humans is lacking. This work fills a critical gap in our understanding of CM pathogenesis that is impeding development of therapeutics. METHODS. Using multiplex immunohistochemistry, we characterized cerebrovascular immune cells in brain sections from 34 children who died from CM or other causes. Children were grouped by clinical diagnosis (CM+ or CM–), iRBC sequestration (Seqhi, Seqlo, Seq0) and HIV status (HIV+ or HIV–). RESULTS. We identified effector CD3+CD8+ T cells engaged on the cerebrovasculature in 69% of CM+ HIV– children. The number of intravascular CD3+CD8+ T cells was influenced by CM status (CM+ > CM–, P = 0.004) and sequestration level (Seqhi > Seqlo, P = 0.010). HIV coinfection significantly increased T cell numbers (P = 0.017) and shifted cells from an intravascular (P = 0.004) to perivascular (P < 0.0001) distribution. CONCLUSION. Within the studied cohort, CM is associated with cerebrovascular engagement of CD3+CD8+ T cells, which is exacerbated by HIV coinfection. Thus, CD3+CD8+ T cells are highly promising targets for CM adjunctive therapy, opening new avenues for the treatment of this deadly disease. FUNDING. This research was supported by the Intramural Research Program of the National Institutes of Health.

7 April 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BRBrittany A. Riggle
Brittany A. Riggle
YWYanfei Wang
Yanfei Wang
Ivan DmochowskiIvan Dmochowski
Ivan Dmochowski

1 December 2014 in Bioconjugate Chemistry
Verified
Journal Article
Open access
NKNajat S. Khan
Najat S. Khan
BRBrittany A. Riggle
Brittany A. Riggle
GSGarry K. Seward
Garry K. Seward
YBYubin Bai
Yubin Bai
Ivan DmochowskiIvan Dmochowski
Ivan Dmochowski
Folate-conjugated cryptophane was developed for targeting cryptophane to membrane-bound folate receptors that are overexpressed in many human cancers. The cryptophane biosensor was synthesized in 20 nonlinear steps, which included functionalization with folate recognition moiety, solubilizing peptide, and Cy3 fluorophore. Hyperpolarized 129Xe NMR studies confirmed xenon binding to the folate-conjugated cryptophane. Cellular internalization of biosensor was monitored by confocal laser scanning microscopy and quantified by flow cytometry. Competitive blocking studies confirmed cryptophane endocytosis through a folate receptor-mediated pathway. Flow cytometry revealed 10-fold higher cellular internalization in KB cancer cells overexpressing folate receptors compared to HT-1080 cells with normal folate receptor expression. The biosensor was determined to be nontoxic in HT-1080 and KB cells by MTT assay at low micromolar concentrations typically used for hyperpolarized 129Xe NMR experiments.

4 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BRBrittany A. Riggle
Brittany A. Riggle
SSSanhita Sinharay
Sanhita Sinharay
WSWilliam Schreiber-Stainthorp
William Schreiber-Stainthorp
JMJeeva P. Munasinghe
Jeeva P. Munasinghe
DMDragan Maric
Dragan Maric
DHDima A Hammoud
Dima A Hammoud
Significance: Cerebral malaria (CM) is the deadliest complication of Plasmodium falciparum infection, resulting in a 15 to 25% mortality rate in African children despite antimalarial chemotherapy. Tragically, nearly a fourth of pediatric CM survivors suffer long-term neurological sequelae. There is an urgent public health and humanitarian need for therapies for CM. In a mouse model of CM, we used magnetic resonance imaging (MRI) to monitor infected mice longitudinally as CM progressed and noninvasively demonstrate that the edema and blood–brain barrier dysfunction, which ultimately result in death, are rapidly reversed by treatment with the glutamine antagonist JHU-083. The similarities between CM MRI shown in mice and those reported in children and adults suggest that glutamine antagonists may be effective CM therapies.

11 July 2012 in Organic Letters
Verified
Journal Article
Open access
OTOleh Taratula
Oleh Taratula
MKMichael P. Kim
Michael P. Kim
YBYubin Bai
Yubin Bai
JPJohn P. Philbin
John P. Philbin
BRBrittany A. Riggle
Brittany A. Riggle
Ivan DmochowskiIvan Dmochowski
Ivan Dmochowski
The efficient synthesis of enantiopure, trisubstituted cryptophane-A derivatives, organic host molecules with unusually high xenon affinity, is reported. Synthesis and chromatographic separation of (±) tri-Mosher’s acid substituted cryptophane diastereomers gave ready access to the enantiopure cryptophanes, which are critical components in the design of enantiomerically pure 129Xe biosensors. Hyperpolarized 129Xe NMR spectroscopy identified single resonances for both trisubstituted cryptophane diastereomers that were separated by 9.5 ppm. This highlights opportunities for using enantiopure xenon biosensors in the simultaneous detection of 129Xe in different biochemical environments.

15 January 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
BRBrittany A Riggle
Brittany A Riggle
LMLouis H Miller
Louis H Miller
SPSusan K. Pierce
Susan K. Pierce
Malaria is a deadly infectious disease caused by parasites of the Plasmodium spp. that takes an estimated 435,000 lives each year, primarily among young African children. For most children, malaria is a febrile illness that resolves with time, but in ∼1% of cases, for reasons we do not understand, malaria becomes severe and life threatening. Cerebral malaria (CM) is the most common form of severe malaria, accounting for the vast majority of childhood deaths from malaria despite highly effective antiparasite chemotherapy. Thus, CM is one of the most prevalent lethal brain diseases, and one for which we have no effective therapy. CM is, in part, an immune-mediated disease, and to fully understand CM, it is essential to appreciate the complex relationship between the malarial parasite and the human immune system. In this study, we provide a primer on malaria for immunologists and, in this context, review progress identifying targets for therapeutic intervention.